Ortho McNeil Pharmaceutical Press Articles

Chain Drug Review - New generics on their way to Rx market

September 26, 2011 --

WASHINGTON -- From extended-release tablets to foam-based formulas to authorized genelics, the generic drug industry continues to introduce a...

continue reading

Business Wire - Diamyd Medical: Diamyd Regains Control of Diabetes Therapy

June 1, 2011 -- HASH(0xaa211f0)

STOCKHOLM -- Regulatory News:

Diamyd Medical AB (STO:DIAMB)(Pink Sheets:DMYDY)...

continue reading

Nordic Business Report - -Diamyd Medical says partner cancels deal for diabetes vaccine

June 1, 2011 --

NORDIC BUSINESS REPORT-June 1, 2011--Diamyd Medical says partner cancels deal for diabetes vaccine(C)2011 M2 COMMUNICATIONS...

continue reading

Chain Drug Review - Topamax recall

May 23, 2011 --

The Ortho-McNeil neurologics division of Ortho-McNeil-Janssen Pharmaceuticals has announced that it is voluntarily recalling two lots of...

continue reading

Business Wire - For the Treatment and Prevention of Venous Thromboembolism, Bayer/Ortho-McNeil’s Xarelto Will Earn Peak-Year Sales of $500 Million to $1 Billion

May 16, 2011 -- HASH(0x13691d30)

However, Xarelto’s Overall Uptake Could Be Constrained By a Perception...

continue reading

Nordic Business Report - -Diamyd Medical moves to net profit of SEK74.3m in Q2 FY 2010

April 14, 2011 --

NORDIC BUSINESS REPORT-April 14, 2011--Diamyd Medical moves to net profit of SEK74.3m in Q2 FY 2010(C)2011 M2 COMMUNICATIONS...

continue reading

Market Wire - Addex Partner Starting Clinical Schizophrenia Trial

March 28, 2011 --

Addex Pharmaceuticals /Addex Partner Starting Clinical Schizophrenia Trial. Processed and transmitted by Thomson Reuters ONE.The issuer is...

continue reading